loader
Please Wait
Applying Filters...
menu
    • menu

    List of Certificates of Suitability (CEPs) for r0_cep_2018_192___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    PharmaCompass Sponsored Ads

    Virtual Booth

    Post An Enquiry

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Cohance Lifesciences

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    Key Products KEY PRODUCTS

    SERVICES

    Key Services KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1ZCL CHEMICALS LTD. Ankleshwar IN

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    ZCL CHEMICALS LTD. Ankleshwar IN

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Clozapine

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    R0-CEP 2018-192 - Rev 01
    Valid
    Chemical
    2021-02-12
    1191
    Cohance

    01

    ZCL CHEMICALS LTD. Ankleshwar IN

    India
    arrow
    CPhI Worldwide, Milan
    Booth #4B1
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Clozapine

    Certificate Number : R0-CEP 2018-192 - Rev 01

    Status : Valid

    Issue Date : 2021-02-12

    Type : Chemical

    Substance Number : 1191

    Cohance

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Looking for Certificates of Suitability (CEPs) for R0-CEP 2018-192 - Rev 01 of Zcl Chemicals Ltd. Ankleshwar In

    Looking for Certificates of Suitability (CEPs) for R0-CEP 2018-192 - Rev 01 of Zcl Chemicals Ltd. Ankleshwar In 1

    20

    Zcl Chemicals Ltd. Ankleshwar In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    They are recognized for Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    One of their significant offerings is Clozapine, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2018-192 - Rev 01

    This Chemical Type CEP, issued on February 12, 2021, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Substance Number 1191 associated with this CEP further emphasizes